Effect of Assistive Technology in patients with Hand OsteoArthritis: A randomised, controlled trial

ISRCTN ISRCTN61534918
DOI https://doi.org/10.1186/ISRCTN61534918
Secondary identifying numbers N/A
Submission date
16/08/2007
Registration date
05/09/2007
Last edited
12/09/2008
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Musculoskeletal Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Ingvild Kjeken
Scientific

Diakonhjemmet Hospital/NRRK
Oslo
0319
Norway

Phone +47 22 45 48 45
Email ingvild.kjeken@nrrk.no

Study information

Study designRandomised controlled trial.
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeOther
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific title
Study acronymATHOA
Study objectivesStudy hypothesis updated as of 08/04/2008:
Although use of assistive technology is a frequent self help strategy in persons with hand osteoarthritis, there is a lack of high quality studies that examine the effect of assistive devices in this group. The aim of this study is to evaluate the effect of provision of assistive technology and patient education compared to patient education alone.

Study hypothesis provided at time of registration:
Although provision of assistive technology is one of the most frequent non-pharmacological, non-surgical interventions for persons with inflammatory rheumatic diseases, there is a lack of high quality studies that examine the effect of this intervention. The aim of this study is to evaluate the effect of provision of assistive technology and patient education compared to patient education alone.
Ethics approval(s)Ethical Committee for Medical Research and the Norwegian Data Inspectorate. Date of approval: 05/03/2008 (ref: 182-07240b 1.2007.1941)
Health condition(s) or problem(s) studiedHand osteoarthritis
InterventionPlease note that, as of 08/04/2008, the anticipated start date of this trial was updated from 01/09/2007 to 15/04/2008.

Participants will be randomly allocated to the following two groups:

Group 1: Provision of assistive technology and patient education
Group 2: Patient education only

Provision of assitive technology includes involving the participants in selecting appropriate device(s) and training in use of the device(s).

Patient education includes provision of information about diagnosis and prognosis, and teaching of energy conservation and alternative working methods.
Intervention typeOther
Primary outcome measurePrimary outcome measures amended as of 22/04/2008:
The following will be assessed at baseline and three months:
1. Activity and participation, measured with the Canadian Occupational Performance Measure (COPM)
2. Pain during performance of prioritised activities, measured on visual analogue scales

Primary outcome measures provided at time of registration:
The following will be measured at baseline, 6 and 12 months:
1. Activity and participation, measured with the Canadian Occupational Performance Measure (COPM)
2. Pain during performance of prioritised activities, measured on visual analogue scales
Secondary outcome measuresSecondary outcome measures amended as of 22/04/2008:
The following will be assessed at baseline and three months:
1. Hand function, measured with the pain, stiffness and function subscales of the Australian/Canadian hand osteoarthritis measure (AUSCAN)
2. Functional ability, measured with the Modified health Assessment Questionnaire (MHAQ)
3. Hand pain, general pain, fatigue and disease activity, measured on visual analogue scales
4. Cost-effectiveness, measured with the Quality of Life Questionnaire (EQ-5D) and patient reported use of medication and health care resources

Secondary outcome measures provided at time of registration:
The following will be measured at baseline and 6 and 12 months:
1. Fatigue, measured with the Fatigue Impact Scale (FIS)
2. Quality of life, measured with the Arthritis Impact Scale (AIMS2)
3. Pain, fatigue and disease activity, measured on visual analogue scales.
4. Functional ability, measured with the Modified Health Assessment Questionnaire (MHAQ).
5. Cost-effectiveness, measured with the Quality of Life Questionnaire (15D) and patient reported use of medications and health care resources
Overall study start date15/04/2008
Completion date31/12/2009

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexNot Specified
Target number of participantsTarget number as of 08/04/2008: 70. Target number at time of registration: 100
Key inclusion criteriaInclusion criteria updated as of 08/04/2008:
1. Age between 18 and 80 years
2. Hand osteoarthritis according to the American College of Rheumatology (ACR) criteria
3. Ability to communicate in Norwegian

Inclusion criteria provided at time of registration:
1. Age between 18 and 75 years
2. Rheumatoid Arthritis (RA), Juvenile Ideopatic Arthritis (JIA) or Psoriatic Arthritis (PsA) according to the American College of Rheumatology (ACR) criteria
3. Ability to communicate in Norwegian
Key exclusion criteriaExclusion criteria updated as of 08/04/2008:
1. Cognitive or mental impairment
2. Hand surgery within the last 6 months
3. Change in medication within the last month
4. Impaired hand function due to trauma or diseases other than hand osteoarthritis

Exclusion criteria provided at time of registration:
1. Surgery within the last 6 months
2. Cognitive impairment or mental disease
3. Change in medication within the last month
4. Need for assistive technology due to surgery or to be able to be discharged from hospital
Date of first enrolment15/04/2008
Date of final enrolment31/12/2009

Locations

Countries of recruitment

  • Norway

Study participating centre

Diakonhjemmet Hospital/NRRK
Oslo
0319
Norway

Sponsor information

Diakonhjemmet Hospital (Norway)
Hospital/treatment centre

Boks 23 Vinderen
Oslo
0319
Norway

Phone +47 22 45 15 00
Email administrasjon@diakonsyk.no
Website http://www.diakonsyk.no
ROR logo "ROR" https://ror.org/02jvh3a15

Funders

Funder type

Hospital/treatment centre

The National Resource Center for Rehabilitation in Rheumatology, Diakonhjemmet Hospital, Oslo (Norway)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan